Browsing: regulating

In a discussion with The Regulatory Review, Gina-Gail S. Fletcher explains how financial regulators should approach both the opportunities and the challenges presented by technological advancements.   Fletcher argues for a harm-based approach to assigning liability for trading misconduct, rather than an intent-based approach, in an era of sophisticated artificial intelligence in which algorithmic trading is prominent. She notes that although regulators’ technological capabilities tend to lag……

The U.S. Food and Drug Administration (FDA) has opened a public consultation on one of the most challenging questions facing modern healthcare technology: how should regulators oversee medical devices powered by generative artificial intelligence (GenAI)? The agency is accepting comments until October 19, 2026, as it considers new approaches to risk assessment, premarket review, and…